For the Inventor, By the Inventor

Enter assignee name

Daejeon, South Korea

Gemvax & Kael Co., Ltd.

USPTO Granted Patents = 41

EPO Patents = 21

Trademarks = 5

Forward Citations = 151

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Sang Jae Kim (40 out of 49 patents)

Hyun-Hee Park (14 out of 39 patents)

Bum Joon Kim (14 out of 18 patents)

4. Woo Jin Lee (14 out of 69 patents)

5. Kyu-Yong Lee (14 out of 14 patents)

6. Seong-Ho Koh (14 out of 14 patents)

7. Sung Jin Huh (14 out of 15 patents)

8. Kyung Hee Kim (14 out of 20 patents)

9. Hwain Jang (2 out of 2 patents)

10. Jung Soon Ha (2 out of 2 patents)

11. Kyuyong Lee (1 out of 1 patent)

12. Seong Ho Koh (1 out of 1 patent)

13. Sangjae Kim (1 out of 1 patent)

14. Bum Joon Kim (16 patents)

Core Competencies:

Anti-Inflammatory Peptides

Cell Penetrating Peptide

Ocular Disease Treatment

Prostate Cancer Composition

Vial Bottle Protector

Telomerase Activity

Hearing Loss Prevention

Cancer Immunotherapy

Angiogenesis Inhibition

Fibrosis Inhibition

Ischemic Damage Treatment

Rheumatoid Arthritis Treatment

41 patents: Sort by Forward Citations

1. 12171812 - Anti-inflammatory peptides and composition comprising the same (2024-12-24),

2. 12168039 - Anti-inflammatory peptides and composition comprising the same (2024-12-17),

3. 12156902 - Anti-inflammatory peptides and composition comprising the same (2024-12-03),

4. 11905536 - Anti-inflammatory peptides and composition comprising the same (2024-02-20),

5. 11857607 - Anti-inflammatory peptides and composition comprising the same (2024-01-02),

6. D1009297 - Vial bottle protector case (2023-12-26),

7. 11844845 - Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate (2023-12-19),

8. 11773381 - Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate (2023-10-03),

9. 11622998 - Anti-inflammatory peptides and composition comprising the same (2023-04-11),

10. 11369665 - Anti-inflammatory peptides and composition comprising the same (2022-06-28),

11. 11098294 - Anti-inflammatory peptides and composition comprising same (2021-08-24),

12. 11077163 - Peptide for treating ocular diseases and composition for treating ocular diseases comprising same (2021-08-03),

13. 11058744 - Composition for treating prostate cancer (2021-07-13),

14. 11015179 - Peptide having anti-viral effect and composition containing same (2021-05-25),

15. 10967000 - Cell-penetrating peptide, conjugate comprising same and composition comprising same (2021-04-06),

GemVax & KAEL Co., Ltd. is a biotechnology company specializing in immunotherapy and cancer research. They are dedicated to developing innovative solutions for the treatment of various cancers, with a focus on personalized medicine and targeted therapies. Through their cutting-edge research and development, GemVax & KAEL aims to improve patient outcomes and transform the field of oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

41 Patents

#24 in Daejeon

#350 in South Korea

#16,223 in the World

Daejeon, South Korea

Gemvax & Kael Co., Ltd.

Forward Citations = 151

13 inventors:

Sang Jae Kim (40 out of 49 patents)

Hyun-Hee Park (14 out of 39 patents)

Bum Joon Kim (14 out of 18 patents)

4. Woo Jin Lee (14 out of 69 patents)

5. Kyu-Yong Lee (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…